German biotech CureVac’s CEO, Franz-Werner Haas, said on Thursday that they are planning to produce 300-400 million doses of their coronavirus vaccine in 2021, as reported by Reuters.
![](https://noortrends.ae/en/wp-content/uploads/2020/07/shutterstock_1642888921-660x330.jpg)
German biotech CureVac’s CEO, Franz-Werner Haas, said on Thursday that they are planning to produce 300-400 million doses of their coronavirus vaccine in 2021, as reported by Reuters.
Tags coronavirus
The minutes of the latest FOMC meeting issued on Wednesday indicated that members of the …